![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
X
20
Wisdom Pharmaceutical Co., Ltd. Haimen Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Gefitinib, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2022-291 - Rev 00
This Chemical Type CEP, issued on April 02, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2866 associated with this CEP further emphasizes